Ibuprofen Lysine Sumarpharma (Ibuprofen D,l-Lysinate)

Ibuprofen lysine works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are required for the synthesis of prostaglandins. By lowering prostaglandin levels, it reduces inflammation, diminishes pain signalling, and lowers elevated body temperature. The lysine salt improves water solubility, leading to faster absorption compared with standard ibuprofen.

The exact dose of Ibuprofen Lysine Sumarpharma is determined by the prescribing healthcare professional based on the individual’s age, weight, and clinical condition. In many over‑the‑counter settings, adult dosing commonly follows the label recommendations, but patients should always follow the specific instructions provided by their doctor or pharmacist.

Safety of ibuprofen lysine in pregnancy has not been definitively established, and it is generally advised to avoid use, especially in the third trimester, unless clearly indicated by a physician. During breastfeeding, small amounts may pass into milk; therefore, a healthcare professional should be consulted before use to weigh potential risks and benefits.

To order Ibuprofen Lysine Sumarpharma from GNH India, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements if applicable) and assistance with import documentation.

Ibuprofen lysine is comparable to standard ibuprofen tablets, but the lysine salt form offers higher aqueous solubility, which can result in faster onset of analgesic effect. Compared with other NSAIDs such as naproxen or diclofenac, its efficacy for pain and fever is similar, while its safety profile aligns with the class‑wide risks of gastrointestinal irritation and renal effects.

Ibuprofen Lysine Sumarpharma tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in bathrooms or near heat sources.

The product is administered orally. Swallow the tablet whole with a full glass of water, preferably with food or milk to reduce potential stomach irritation. Do not crush, chew, or split the tablet unless instructed by a healthcare professional.

The most serious risks associated with ibuprofen lysine include gastrointestinal bleeding or ulceration, severe renal impairment, and hypersensitivity reactions such as anaphylaxis. Patients should be alert for signs of black stools, sudden kidney dysfunction, swelling, rash, or breathing difficulties and seek immediate medical attention if these occur.

Ibuprofen Lysine Sumarpharma should be avoided in individuals with known hypersensitivity to ibuprofen or other NSAIDs, active peptic ulcer disease, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment. It is also contraindicated in the third trimester of pregnancy and in patients receiving anticoagulant therapy without close medical supervision.